160 related articles for article (PubMed ID: 32748196)
1. Clinical significance of phenotyping and karyotyping of detecting circulating tumor cells in renal cell carcinoma using subtraction enrichment and immunostaining-fluorescence in situ hybridization (SE-iFISH).
Tian D; Zhang M; Zheng G; Zhang Y; Li Y; Lin P; Li H; Jiao W; Niu H
Int Urol Nephrol; 2020 Dec; 52(12):2281-2287. PubMed ID: 32748196
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of pancreatic circulating tumor cells using combined negative enrichment and immunostaining-fluorescence in situ hybridization.
Gao Y; Zhu Y; Zhang Z; Zhang C; Huang X; Yuan Z
J Exp Clin Cancer Res; 2016 Apr; 35():66. PubMed ID: 27066900
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of detecting circulating tumor cells in colorectal cancer using subtraction enrichment and immunostaining-fluorescence in situ hybridization (SE-iFISH).
Wu W; Zhang Z; Gao XH; Shen Z; Jing Y; Lu H; Li H; Yang X; Cui X; Li Y; Lou Z; Liu P; Zhang C; Zhang W
Oncotarget; 2017 Mar; 8(13):21639-21649. PubMed ID: 28423493
[TBL] [Abstract][Full Text] [Related]
4. Enhanced detection and comprehensive in situ phenotypic characterization of circulating and disseminated heteroploid epithelial and glioma tumor cells.
Ge F; Zhang H; Wang DD; Li L; Lin PP
Oncotarget; 2015 Sep; 6(29):27049-64. PubMed ID: 26267323
[TBL] [Abstract][Full Text] [Related]
5. Circulating tumor cells with karyotyping as a novel biomarker for diagnosis and treatment of nasopharyngeal carcinoma.
Zhang J; Shi H; Jiang T; Liu Z; Lin PP; Chen N
BMC Cancer; 2018 Nov; 18(1):1133. PubMed ID: 30454007
[TBL] [Abstract][Full Text] [Related]
6. Combined detection and subclass characteristics analysis of CTCs and CTECs by SE-iFISH in ovarian cancer.
Cheng H; Wang S; Luan W; Ye X; Dou S; Tang Z; Zhu H; Lin PP; Li Y; Cui H; Chang X
Chin J Cancer Res; 2021 Apr; 33(2):256-270. PubMed ID: 34158744
[TBL] [Abstract][Full Text] [Related]
7. [Detection of Circulating Tumor Cells in Bladder Cancer by Subtraction Enrichment and Immunostaining-fluorescence
Yang YB; Bai YJ; Tang Y; Liu ZH; Wei Q; Han P
Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Jul; 48(4):605-609. PubMed ID: 28752983
[TBL] [Abstract][Full Text] [Related]
8. Comparison of analytic performances of Cellsearch and iFISH approach in detecting circulating tumor cells.
Sheng Y; Wang T; Li H; Zhang Z; Chen J; He C; Li Y; Lv Y; Zhang J; Xu C; Wang Z; Huang C; Wang L
Oncotarget; 2017 Jan; 8(5):8801-8806. PubMed ID: 28187533
[TBL] [Abstract][Full Text] [Related]
9. Improvement of sensitive and specific detection of circulating tumor cells using negative enrichment and immunostaining-FISH.
Li Y; Ma G; Zhao P; Fu R; Gao L; Jiang X; Hu P; Ren T; Wu Y; Wang Z; Cui Z; Yang D
Clin Chim Acta; 2018 Oct; 485():95-102. PubMed ID: 29940145
[TBL] [Abstract][Full Text] [Related]
10. Detecting and phenotyping of aneuploid circulating tumor cells in patients with various malignancies.
Ye Z; Ding Y; Chen Z; Li Z; Ma S; Xu Z; Cheng L; Wang X; Zhang X; Ding N; Zhang Q; Qian Q
Cancer Biol Ther; 2019; 20(4):546-551. PubMed ID: 30572767
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of phenotyping and karyotyping of circulating tumor cells in patients with advanced gastric cancer.
Li Y; Zhang X; Ge S; Gao J; Gong J; Lu M; Zhang Q; Cao Y; Wang DD; Lin PP; Shen L
Oncotarget; 2014 Aug; 5(16):6594-602. PubMed ID: 25026283
[TBL] [Abstract][Full Text] [Related]
12. Detection of Circulating Tumor Cells Using Negative Enrichment Immunofluorescence and an In Situ Hybridization System in Pancreatic Cancer.
Xu Y; Qin T; Li J; Wang X; Gao C; Xu C; Hao J; Liu J; Gao S; Ren H
Int J Mol Sci; 2017 Mar; 18(4):. PubMed ID: 28333072
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of circulating tumor cells detection in renal cell carcinoma with thrombus: A STROBE-compliant study.
Ge L; Song Y; Yang F; Zhao G; Lu M; Zhang S; Ma L
Medicine (Baltimore); 2020 May; 99(22):e20615. PubMed ID: 32481476
[TBL] [Abstract][Full Text] [Related]
14. CTCs detection from intraoperative salvaged blood in RCC-IVC thrombus patients by negative enrichment and iFISH identification: a preliminary study.
Zhang X; Guo X; Zong Y; Xu C; Wang J; Zhang B; Liu C; Gong Y; Xue L; Ma L; Zhang S; Li Y; Zeng H
BMC Urol; 2021 Jun; 21(1):89. PubMed ID: 34112129
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive in situ co-detection of aneuploid circulating endothelial and tumor cells.
Lin PP; Gires O; Wang DD; Li L; Wang H
Sci Rep; 2017 Aug; 7(1):9789. PubMed ID: 28852197
[TBL] [Abstract][Full Text] [Related]
16. Circulating Tumor Cells as a Biomarker in Pancreatic Ductal Adenocarcinoma.
Liu H; Sun B; Wang S; Liu C; Lu Y; Li D; Liu X
Cell Physiol Biochem; 2017; 42(1):373-382. PubMed ID: 28558380
[TBL] [Abstract][Full Text] [Related]
17. [A Rare Case of Extremely High Counts of EpCAM
Jiang TT; Li HP; Li YC
Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Jul; 53(4):711-715. PubMed ID: 35871746
[TBL] [Abstract][Full Text] [Related]
18. Karyotyping of circulating tumor cells for predicting chemotherapeutic sensitivity and efficacy in patients with esophageal cancer.
Chen Y; Yang Z; Wang Y; Wang J; Wang C
BMC Cancer; 2019 Jul; 19(1):651. PubMed ID: 31269908
[TBL] [Abstract][Full Text] [Related]
19. Optimal Strategy for Colorectal Cancer Patients' Diagnosis Based on Circulating Tumor Cells and Circulating Tumor Endothelial Cells by Subtraction Enrichment and Immunostaining-Fluorescence In Situ Hybridization Combining with CEA and CA19-9.
Luo S; Ou Y; Zheng T; Jiang H; Wu Y; Zhao J; Zhang Z
J Oncol; 2021; 2021():1517488. PubMed ID: 34976053
[TBL] [Abstract][Full Text] [Related]
20. Integrated EpCAM-independent subtraction enrichment and iFISH strategies to detect and classify disseminated and circulating tumors cells.
Lin PP
Clin Transl Med; 2015 Dec; 4(1):38. PubMed ID: 26718583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]